Medicus Pharma Ltd (MDCX)
NASDAQ:MDCX
Total Valuation
Medicus Pharma Ltd has a market cap or net worth of $18.07M. The enterprise value is $6.90M.
Market Cap$18.07M
Enterprise Value$6.90M
Share Statistics
Medicus Pharma Ltd has 39,362,110 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding39,362,110
Owned by Insiders13.79%
Owned by Institutions13.57%
Financial Efficiency
Medicus Pharma Ltd’s return on equity (ROE) is 375.50 and return on invested capital (ROIC) is -452.42%.
Return on Equity (ROE)375.50
Return on Assets (ROA)-2.52
Return on Invested Capital (ROIC)-452.42%
Return on Capital Employed (ROCE)-148.82
Revenue Per Employee0.00
Profits Per Employee-2.95M
Employee Count12
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medicus Pharma Ltd is ―. Medicus Pharma Ltd’s PEG ratio is -0.01.
PE Ratio―
PS Ratio0.00
PB Ratio-391.45
Price to Fair Value-391.45
Price to FCF-1.16
Price to Operating Cash Flow-0.55
PEG Ratio-0.01
Income Statement
In the last 12 months, Medicus Pharma Ltd had revenue of 0.00 and earned -25.37M in profits. Earnings per share was -1.96.
Revenue0.00
Gross Profit0.00
Operating Income-18.35M
Pretax Income-25.37M
Net Income-25.37M
EBITDA-18.35M
Earnings Per Share (EPS)-1.96
Cash Flow
In the last 12 months, operating cash flow was -20.84M and capital expenditures 3.00, giving a free cash flow of -20.84M billion.
Operating Cash Flow-20.84M
Free Cash Flow-20.84M
Free Cash Flow per Share-0.53
Dividends & Yields
Medicus Pharma Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.61
52-Week Price Change-86.50%
50-Day Moving Average0.94
200-Day Moving Average1.95
Relative Strength Index (RSI)33.37
Average Volume (3m)7.40M
Important Dates
Medicus Pharma Ltd upcoming earnings date is May 28, 2026, After Close (Confirmed).
Last Earnings DateMar 25, 2026
Next Earnings DateMay 28, 2026
Ex-Dividend Date―
Financial Position
Medicus Pharma Ltd as a current ratio of 1.00, with Debt / Equity ratio of -8107.67%
Current Ratio1.00
Quick Ratio1.00
Debt to Market Cap0.15
Net Debt to EBITDA0.26
Interest Coverage Ratio-129.91
Taxes
In the past 12 months, Medicus Pharma Ltd has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Medicus Pharma Ltd EV to EBITDA ratio is -1.18, with an EV/FCF ratio of -0.95.
EV to Sales0.00
EV to EBITDA-1.18
EV to Free Cash Flow-0.95
EV to Operating Cash Flow-0.95
Balance Sheet
Medicus Pharma Ltd has $6.35M in cash and marketable securities with $4.00M in debt, giving a net cash position of $2.36M billion.
Cash & Marketable Securities$6.35M
Total Debt$4.00M
Net Cash$2.36M
Net Cash Per Share$0.06
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Medicus Pharma Ltd is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside310.96% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast-55.95%